Hypertonic Lactate After Cardiac Arrest

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 125 participants.

Also called NCT05004610

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 125 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05004610
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Belgium (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05004610. Randomized; single masking; primary purpose treatment. Start 2025-02-19 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Hypertonic Lactate After Cardiac Arrest
Acronym
LATTE
Condition
Ischemia Reperfusion Injury
Condition
Anoxic Brain Injury
Intervention (Drug)
Sodium Lactate Solution
Lead sponsor
Erasme University Hospital (class: other)

Record details

Record id
cardio:ct-nct05004610
Content hash
4f288d9253f34c669dfe9403e3878669ac38d6fc6c887b65690eb101405ab1f3